Phase Holographic Imaging Launches Wound Healing Assay
Phase Holographic Imaging today launches the HoloMonitor® Wound Healing Assay. The assay meets the unmet market demand of both quantifying cell movement automatically and in great detail. Wound healing assays are one of the most used laboratory methods to study cell movement. Conventional wound healing assays are either manual or just measure the collective movement of a cell population.
About Wound Healing Assays
By creating a “wound” in cultured cells, wound healing assays mimic the cell movement in living organisms. The method is, however, manual and labor intensive, especially when measuring the movement of individual cells. In preclinical research, this often results in that individual cell movement is ignored; even though individual cell movement is of crucial importance in the formation of metastasis, for example. With the HoloMonitor Wound Healing Assay, cell movement is rapidly quantified both on a population level and on an individual cell level, characterized by:
- Cell friendly — label-free
- User friendly — set-up and walk away
- Automatic quantification of “wound” closure
- Quantification of individual cell movement by cell tracking
Image sequence of a “wound” closure
For further information, please visit: www.phiab.se/applications/wound-healing.
For additional information, please contact:
Peter Egelberg, CEO
Tel: +46 703 19 42 74
E-mail: peter.egelberg@phiab.se
Web: www.phiab.se
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.
